May 16, 2024
The US Attorney General has initiated the process to reclassify cannabis from a Schedule I to a less-restrictive Schedule III substance.
May 14, 2024
At the Cannabis Science Conference, Antonio Timoteo Jr., PhD, presented research on cannabis cultivation practices and optimizing terpene content.
May 10, 2024
In the Cultivation Track at Cannabis Science Conference, Bernie Lorenz, Chief Science Officer of ProKure Solutions, discussed the intriguing topic of the effects of COVID on cannabis testing methods.
In the General Session of the Cannabis Science Conference, Scheril Murray Powell, Esq. and John Calloway Jr. discussed the many ways equity ties into science in the cannabis industry.
April 30, 2024
Multiple sources have reported that the US Drug Enforcement Administration will move to reclassify marijuana from Schedule I to Schedule III, effectively recognizing medical uses of cannabis and its reduced potential for abuse compared with other drugs.
April 25, 2024
In the second installment in this webinar series, Dr. Marion McNabb and Dr. Peter Grinspoon discuss implementation of cannabis as a harm reduction agent from a clinical perspective.
April 24, 2024
Our sister publication, LCGC International, sat down with Zacariah Hildenbrand, PhD, Chief Science Officer of Infinity Water Solutions and Partner of Medusa Analytical, for more insight into various trends in cannabis testing.
April 23, 2024
Kentucky Governor signs HB 829, and introduces lottery for dispensary applications.
April 22, 2024
Trilogene Seeds recently announced the release of their new triploid THCa cannabis seeds.
April 20, 2024
In recognizing the 4/20 holiday, here is a selection of regulatory updates and commentary in the cannabis industry this year so far.